The drug combo of daclatasvir from BMS and Gilead’s GS-7977 reached a 100% sustained virologic response (SVR), or cure rate, at week four in one common subgroup, genotype 1 patients who have not been ...
A Bristol Myers Squibb drug that the pharmaceutical giant added to its pipeline via a multi-billion dollar acquisition now has FDA approval, a decision that makes it the first authorized treatment for ...
A new digital/pharma partnership. Amid a breakdown of its new strategic direction, Paris-based Voluntis announced a new partnership with Bristol-Myers Squibb that aims to support cancer patients with ...
Touchscreen interface, smart app connectivity, and BMS integration simplify setup and maximize energy efficiency. NEW CASTLE, Pa.--(BUSINESS WIRE)--Berner International, North America’s leading ...
One of the two companies that markets CAR-T cell therapies for blood cancer will have to pay more than $700 million to a competing company and a cancer hospital over allegations that its product ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback